• LAST PRICE
    1.6100
  • TODAY'S CHANGE (%)
    Trending Down-0.0800 (-4.7337%)
  • Bid / Lots
    1.5500/ 50
  • Ask / Lots
    1.6600/ 4
  • Open / Previous Close
    1.6700 / 1.6900
  • Day Range
    Low 1.5400
    High 1.6999
  • 52 Week Range
    Low 1.0727
    High 16.7225
  • Volume
    69,882
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.69
TimeVolumeCFMS
09:32 ET15401.68
09:34 ET6801.6615
09:45 ET5001.65
09:48 ET5001.68
09:52 ET5731.69
09:54 ET1001.6908
10:01 ET248991.63
10:03 ET29741.63
10:10 ET43701.6347
10:21 ET38001.6
10:24 ET60901.5801
10:26 ET98791.54
10:32 ET7001.56
10:48 ET1001.5884
10:51 ET5871.5685
11:02 ET1201.56
11:04 ET27231.5758
11:33 ET1021.6037
11:36 ET4001.615
11:40 ET1001.58
11:44 ET1001.58
11:45 ET2001.6246
12:20 ET3001.6
12:32 ET4801.58
12:34 ET2001.58
12:36 ET10001.6
12:39 ET3801.6008
12:48 ET1181.6017
01:15 ET1871.6188
01:33 ET2001.62
01:44 ET2001.61
01:51 ET2001.6199
02:40 ET1001.64
03:09 ET2001.6328
03:16 ET5841.62
03:23 ET6001.629
03:32 ET7321.62
03:54 ET3001.61
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCFMS
Conformis Inc
12.1M
-0.2x
---
United StatesBIOC
Biocept Inc
5.8M
-0.3x
---
United StatesTRIB
Trinity Biotech PLC
19.6M
-0.5x
---
United StatesSIEN
Sientra Inc
15.6M
-0.1x
---
United StatesAZYO
Aziyo Biologics Inc
24.4M
-0.6x
---
United StatesSRGA
Surgalign Holdings Inc
10.8M
-0.1x
---
As of 2023-04-01

Company Information

Conformis, Inc. is a medical technology company. The Company is engaged in the development, manufacturing, and sales of patient-specific products and instrumentation that are individually sized and shaped to fit each patient's various knee and hip anatomy. The Company offers knee replacement products and knee replacement products. The Company's product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant Platinum Services Program, as well as data-informed, standardized solutions that combine many benefits of personalization with an off-the-shelf system. Its sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. The Company owns or in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

Contact Information

Headquarters
600 Technology DriveBILLERICA, MA, United States 01821
Phone
781-345-9001
Fax
781-345-0147

Executives

Independent Chairman of the Board
Kenneth Fallon
President, Chief Executive Officer, Director
Mark Augusti
Chief Financial Officer, Treasurer
Robert Howe
Chief Operating Officer
Michael Fillion
Chief Legal Officer, Corporate Secretary
Denise Pedulla

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$12.1M
Revenue (TTM)
$62.1M
Shares Outstanding
7.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.09
EPS
$-7.00
Book Value
$7.22
P/E Ratio
-0.2x
Price/Sales (TTM)
0.2
Price/Cash Flow (TTM)
---
Operating Margin
-74.58%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.